Selain Blog Mesothelioma yang lain, saya juga mo nulis dukungan SEO kontes buat Proxy Server di blog ini (mesothelioma juga). Tema kontes itu adalah Kampanye Damai Pemilu Indonesia 2009 mohon dukungannya juga yaa... Makasih banyak.
MESOTHELIOMA LAWYER
Kazan Law, Mesothelioma Lawyer
Who is Kazan Law?
Since its founding in 1974, Kazan, McClain, Lyons, Greenwood & Harley, A Professional Law Corporation, has represented many hundreds of people with cancer, especially people suffering from mesothelioma, a cancer whose only known cause is exposure to asbestos. Some of the principals in this law firm are pioneers in asbestos litigation and among the most experienced mesothelioma lawyer in California.
The Firm has a nationwide practice and reputation in asbestos litigation. We have represented clients across the United States, and in Canada, Mexico and the United Kingdom.
Our Firm & Practice
On this website you can gather more information about different types of asbestos fibers and products, learn about asbestos-related diseases (such as mesothelioma, asbestosis and lung cancer), become aware of new medical treatment options, and understand The Firm's role in the history of asbestos litigation. Finally, for a no-cost evaluation of your potential case, you can easily contact an experienced asbestos lawyer in California by calling our toll-free phone number or sending us an email.
Understanding Asbestos Litigation
When a potential client with mesothelioma approaches our office, the initial contact is often with our intake department. This starts an information-gathering process. We ask potential clients to provide us with essential information about themselves, their family members, their work history, their exposure to asbestos, and their medical history. We also obtain releases so that we can order employment and medical records. As soon as we have sufficient information, we decide if we can recommend filing suit and if our firm can represent this person. Read more about Asbestos Litigation & Lawsuits…
What does asbestos have to do with mesothelioma?
The only known cause of mesothelioma in the U.S. is previous exposure to asbestos fibers. Asbestos manufacturers knew about the hazards of asbestos seventy years ago - but they kept this knowledge to themselves. The first warnings to workers exposed to asbestos were given in the mid-1960s, and they were terribly inadequate. Even today, workers are not always told they are working around asbestos and are at risk for asbestos disease. Read our mesothelioma facts newsletter…
Mesothelioma & Asbestos Related Disease
Recognizing early symptoms of malignant mesothelioma may aid in diagnosis. Symptoms include difficulty in breathing (dyspnea) and/or chest pains, fever, nausea or anemia; other signals are hoarseness, difficulty swallowing (dysphagia), or coughing up blood (hemoptysis). For many suffering from pleural mesothelioma, there may be pain in the chest or lower back. Those people with peritoneal mesothelioma may experience an expanding waist size or abdominal pain resulting from the growth of cancer cells in the abdomen.
Since many of these symptoms are also caused by less serious illnesses, it can be difficult to recognize asbestos-related diseases in the early stages. Due to this difficulty of early diagnosis of asbestos cancer and mesothelioma, the best way to determine your health risk is to consult a doctor for an initial examination, which may include a pulmonary function test (PFT) and x-rays Read more about mesothelioma symptoms, types and treatment options…
If you need information about asbestos exposure or disease, or have questions about filing an asbestos lawsuit, please take a look at the FAQs (frequently-asked questions), or contact us directly. You might also want to read some of the feedback that we've received about our work and web site. KazanLaw.com changes frequently, so please come back and visit it soon. Mesothelioma Lawyer
Since its founding in 1974, Kazan, McClain, Lyons, Greenwood & Harley, A Professional Law Corporation, has represented many hundreds of people with cancer, especially people suffering from mesothelioma, a cancer whose only known cause is exposure to asbestos. Some of the principals in this law firm are pioneers in asbestos litigation and among the most experienced mesothelioma lawyer in California.
The Firm has a nationwide practice and reputation in asbestos litigation. We have represented clients across the United States, and in Canada, Mexico and the United Kingdom.
Our Firm & Practice
On this website you can gather more information about different types of asbestos fibers and products, learn about asbestos-related diseases (such as mesothelioma, asbestosis and lung cancer), become aware of new medical treatment options, and understand The Firm's role in the history of asbestos litigation. Finally, for a no-cost evaluation of your potential case, you can easily contact an experienced asbestos lawyer in California by calling our toll-free phone number or sending us an email.
Understanding Asbestos Litigation
When a potential client with mesothelioma approaches our office, the initial contact is often with our intake department. This starts an information-gathering process. We ask potential clients to provide us with essential information about themselves, their family members, their work history, their exposure to asbestos, and their medical history. We also obtain releases so that we can order employment and medical records. As soon as we have sufficient information, we decide if we can recommend filing suit and if our firm can represent this person. Read more about Asbestos Litigation & Lawsuits…
What does asbestos have to do with mesothelioma?
The only known cause of mesothelioma in the U.S. is previous exposure to asbestos fibers. Asbestos manufacturers knew about the hazards of asbestos seventy years ago - but they kept this knowledge to themselves. The first warnings to workers exposed to asbestos were given in the mid-1960s, and they were terribly inadequate. Even today, workers are not always told they are working around asbestos and are at risk for asbestos disease. Read our mesothelioma facts newsletter…
Mesothelioma & Asbestos Related Disease
Recognizing early symptoms of malignant mesothelioma may aid in diagnosis. Symptoms include difficulty in breathing (dyspnea) and/or chest pains, fever, nausea or anemia; other signals are hoarseness, difficulty swallowing (dysphagia), or coughing up blood (hemoptysis). For many suffering from pleural mesothelioma, there may be pain in the chest or lower back. Those people with peritoneal mesothelioma may experience an expanding waist size or abdominal pain resulting from the growth of cancer cells in the abdomen.
Since many of these symptoms are also caused by less serious illnesses, it can be difficult to recognize asbestos-related diseases in the early stages. Due to this difficulty of early diagnosis of asbestos cancer and mesothelioma, the best way to determine your health risk is to consult a doctor for an initial examination, which may include a pulmonary function test (PFT) and x-rays Read more about mesothelioma symptoms, types and treatment options…
If you need information about asbestos exposure or disease, or have questions about filing an asbestos lawsuit, please take a look at the FAQs (frequently-asked questions), or contact us directly. You might also want to read some of the feedback that we've received about our work and web site. KazanLaw.com changes frequently, so please come back and visit it soon. Mesothelioma Lawyer
New Diagnostic Test For Mesothelioma
Mesothelioma is incredibly difficult to diagnose because it is so often confused for other types of cancer. Because of this, there has been a great deal of research into the best way to diagnose mesothelioma accurately and early. This research has led to the new diagnostic test called miRview meso.
This new test differentiates mesothelioma from other types of cancer. While this test is a step in the right direction, there is still no diagnostic test that can be entirely conclusive on its own. Using miRview meso along with other diagnostic testing, however, can give definitive results.
Because mesothelioma is so hard to diagnose, it is also very difficult to treat. If you or someone you know has been diagnosed with mesothelioma, contact the New York mesothelioma attorneys of Williams Kherkher at 800-220-9341.
See Malignant Pleural Mesothelioma Trial Results, from The Lancet >>>
This new test differentiates mesothelioma from other types of cancer. While this test is a step in the right direction, there is still no diagnostic test that can be entirely conclusive on its own. Using miRview meso along with other diagnostic testing, however, can give definitive results.
Because mesothelioma is so hard to diagnose, it is also very difficult to treat. If you or someone you know has been diagnosed with mesothelioma, contact the New York mesothelioma attorneys of Williams Kherkher at 800-220-9341.
See Malignant Pleural Mesothelioma Trial Results, from The Lancet >>>
Malignant Pleural Mesothelioma Trial Results, from The Lancet
Malignant Pleural Mesothelioma Trial Results, from The Lancet
A recent article published in The Lancet, one of the world's leading medical journals (and a fan of our website!), once again demonstrates that there is as yet no really good treatment for Mesothelioma. The article focused on an analysis of a multicentre randomized trial to determine whether adding chemotherapy to active symptom control in the treatment of patients with malignant pleural mesothelioma made any difference. It noted:
"Malignant pleural mesothelioma is almost always fatal, and few treatment options are available. Although active symptom control (ASC) has been recommended for the management of this disease, no consensus exists for the role of chemotherapy. We investigated whether the addition of chemotherapy to ASC improved survival and quality of life."
Regrettably, the authors concluded:
"We observed no between-group differences in four predefined quality-of-life subscales (physical functioning, pain, dyspnoea, and global health status) at any of the assessments in the first 6 months."
which means that "The addition of chemotherapy to ASC offers no significant benefits in terms of overall survival or quality of life."
It still seems that the best hope for mesothelioma patients and their families is renewed efforts to understand how this disease evolves and find new treatment methods. This further highlights the overwhelming importance of eliminating future asbestos exposure in an effort to prevent future cases of this as-yet-incurable disease.
Read the abstract on this trial of 409 patients with malignant pleural mesothelioma.
See Genetic Susceptibility to Malignant >>>
A recent article published in The Lancet, one of the world's leading medical journals (and a fan of our website!), once again demonstrates that there is as yet no really good treatment for Mesothelioma. The article focused on an analysis of a multicentre randomized trial to determine whether adding chemotherapy to active symptom control in the treatment of patients with malignant pleural mesothelioma made any difference. It noted:
"Malignant pleural mesothelioma is almost always fatal, and few treatment options are available. Although active symptom control (ASC) has been recommended for the management of this disease, no consensus exists for the role of chemotherapy. We investigated whether the addition of chemotherapy to ASC improved survival and quality of life."
Regrettably, the authors concluded:
"We observed no between-group differences in four predefined quality-of-life subscales (physical functioning, pain, dyspnoea, and global health status) at any of the assessments in the first 6 months."
which means that "The addition of chemotherapy to ASC offers no significant benefits in terms of overall survival or quality of life."
It still seems that the best hope for mesothelioma patients and their families is renewed efforts to understand how this disease evolves and find new treatment methods. This further highlights the overwhelming importance of eliminating future asbestos exposure in an effort to prevent future cases of this as-yet-incurable disease.
Read the abstract on this trial of 409 patients with malignant pleural mesothelioma.
See Genetic Susceptibility to Malignant >>>
Genetic Susceptibility to Malignant Mesothelioma
Genetic Susceptibility to Malignant Mesothelioma?
Over the last 30 or so years, I've represented family members of mesothelioma patients who themselves develop mesothelioma, and so have other plaintiffs attorneys.
Doctors and researchers working with the victims of mesothelioma began to publish reports of clusters of the disease. A 2004 survey of 610 pleural mesotheliomas (Bianchi, Ind Health 2004 Apr 42(2):235-9: Familial Mesothelioma of the Pleura) found 40 familial cases. While it is likely that shared asbestos exposure is a major factor, researchers are now exploring the possibility that genetic factors might play a role in determining the susceptibility to asbestos-related cancer. A recent article explores this possibility (Ugolini, Mutat Res 2008 Mar-Apr 658 (3):162-71: Genetic susceptibility to malignant mesothelioma and exposure to asbestos: the influence of the familial factor).
Ugolini analyzed cases of clustering in reported medical literature and concluded that the available medical literature supports the hypothesis that familial clustering of malignant mesothelioma is largely attributable to shared asbestos exposure. The additional contribution of factors dealing with genetic susceptibility may also play a role. This is important as the understanding of the genetic profiling of malignant mesothelioma may lead to new preventive and therapeutic treatments for this devastating disease, at least in some cases.
Anything we can learn about mesothelioma's development can only be helpful in the worldwide effort to find a cure. It remains true, however, that the best treatment is still prevention, so efforts to ban asbestos and protect workers and their families from all exposures must remain our goal.
See India's Asbestos Time Bomb >>>
Over the last 30 or so years, I've represented family members of mesothelioma patients who themselves develop mesothelioma, and so have other plaintiffs attorneys.
Doctors and researchers working with the victims of mesothelioma began to publish reports of clusters of the disease. A 2004 survey of 610 pleural mesotheliomas (Bianchi, Ind Health 2004 Apr 42(2):235-9: Familial Mesothelioma of the Pleura) found 40 familial cases. While it is likely that shared asbestos exposure is a major factor, researchers are now exploring the possibility that genetic factors might play a role in determining the susceptibility to asbestos-related cancer. A recent article explores this possibility (Ugolini, Mutat Res 2008 Mar-Apr 658 (3):162-71: Genetic susceptibility to malignant mesothelioma and exposure to asbestos: the influence of the familial factor).
Ugolini analyzed cases of clustering in reported medical literature and concluded that the available medical literature supports the hypothesis that familial clustering of malignant mesothelioma is largely attributable to shared asbestos exposure. The additional contribution of factors dealing with genetic susceptibility may also play a role. This is important as the understanding of the genetic profiling of malignant mesothelioma may lead to new preventive and therapeutic treatments for this devastating disease, at least in some cases.
Anything we can learn about mesothelioma's development can only be helpful in the worldwide effort to find a cure. It remains true, however, that the best treatment is still prevention, so efforts to ban asbestos and protect workers and their families from all exposures must remain our goal.
See India's Asbestos Time Bomb >>>
India's Asbestos Time Bomb
Related to Mesothelioma Lawyer
On September 25, at simultaneous events in Amsterdam at the IMIG meeting and in India, the International Ban Asbestos Secretariat’s latest publication, India’s Asbestos Time Bomb, was presented to the world. We are pleased and proud to announce that copies are available for reading and in downloadable .pdf format on the WorldAsbestosReport.org web site at no cost. Our firm has sponsored the presentation of complimentary copies to all IMIG attendees and has been given exclusive North American rights to publish this volume online. We encourage people to read this volume. As you will see from even a brief review, this is an excellent work that cost a great deal to prepare. I am sure that IBAS would welcome contributions of any amount to help defray those costs and to support similar work in the future. Information on direct contributions can be found on the IBAS web site. For those in the United States who would prefer to make contributions in dollars, they can be sent to our Foundation, which will collect such contributions and forward them intact to IBAS.
This work contains articles placing India’s asbestos debate into its appropriate political context, both with respect to Indian government complicity in the asbestos scandal and with respect to the discussion about the true hazards of chrysotile asbestos. There are articles discussing the extent of exposure in India, the problems related to the ship-breaking industry, as previously discussed at length in another IBAS publication, Killing the Future, also available on WorldAsbestosReport.org in English, Japanese, Chinese, and Bangla. There are articles dealing with the hazards of asbestos cement roofing materials used in the construction of homes for India’s poor, the problems inherent in attempting to monitor asbestos exposure in a society like India, the extent of asbestos-related disease in India and the degree to which it has been unreported, the frustrating struggles of Indian workers and unions to obtain fair and efficient compensation for asbestos victims, and the scandalous history of western multinational corporations like Turner & Newall which have done massive asbestos business in India, leaving behind a legacy of death and disease.
This book is a credit to its authors and the organizations with which they work. It is a demonstration of courage and perseverance against appalling odds that this work could be done and done so well. It is also a credit to India’s great democratic traditions; one can only hope that the Indian government will be strong and responsive enough to deal with these problems for the benefit of all its citizens.
This work contains articles placing India’s asbestos debate into its appropriate political context, both with respect to Indian government complicity in the asbestos scandal and with respect to the discussion about the true hazards of chrysotile asbestos. There are articles discussing the extent of exposure in India, the problems related to the ship-breaking industry, as previously discussed at length in another IBAS publication, Killing the Future, also available on WorldAsbestosReport.org in English, Japanese, Chinese, and Bangla. There are articles dealing with the hazards of asbestos cement roofing materials used in the construction of homes for India’s poor, the problems inherent in attempting to monitor asbestos exposure in a society like India, the extent of asbestos-related disease in India and the degree to which it has been unreported, the frustrating struggles of Indian workers and unions to obtain fair and efficient compensation for asbestos victims, and the scandalous history of western multinational corporations like Turner & Newall which have done massive asbestos business in India, leaving behind a legacy of death and disease.
This book is a credit to its authors and the organizations with which they work. It is a demonstration of courage and perseverance against appalling odds that this work could be done and done so well. It is also a credit to India’s great democratic traditions; one can only hope that the Indian government will be strong and responsive enough to deal with these problems for the benefit of all its citizens.
International Mesothelioma Interest Groub
Our law firm once again helped support the world's premier gathering of international mesothelioma clinicians, researchers and scientists which was convened by the International Mesothelioma Interest Group. This year's event took place from September 25-27, 2008 at the De Meervart conference venue in Amsterdam.
In addition to being Silver Sponsors of IMIG, the Partners wanted to recognize the work of up and coming researchers by awarding prizes to young investigators, while also honoring the work of the International Ban Asbestos Secretariat (IBAS) and the Asbestos Disease Awareness Organization (ADAO), leaders in the campaign for a global asbestos ban and justice for asbestos victims. These awards were presented by Laurie Kazan-Allen, the IBAS Coordinator, and Linda Reinstein, Executive Director of the ADAO. During the award ceremony, Mrs. Reinstein told the 300 attendees that when her husband Alan was diagnosed with mesothelioma, the first thing they did was to search the IMIG website looking for medical experts; the help and support of IMIG members during Alan's illness was of inestimable importance to the family and, although sadly Alan lost his fight for life, the hope that one day a cure may be found for this deadly disease motivates her to continue ADAO's fight.
The winners of the 2008 IBAS and ADAO Young Investigators awards, selected by the IMIG Scientific Board and worth €2000 (approximately $2500) each, were announced on September 27 at the closing session of the conference. The 2008 IBAS and ADAO award recipients were:
• Dr. Jenette Creaney from the National Centre for Asbestos-related Disease Research, University of Western Australia for her abstract: The use of mesothelin for monitoring patients with mesothelioma
• Dr. Yasumitsu Nishimura from the Department of Hygiene, Kawasaki Medical School, Okayama, Japan for his abstract: Impairment in cytotoxicity and expression of NK-cell activating receptors on human NK cells caused by exposure to asbestos fibers.
In addition to being Silver Sponsors of IMIG, the Partners wanted to recognize the work of up and coming researchers by awarding prizes to young investigators, while also honoring the work of the International Ban Asbestos Secretariat (IBAS) and the Asbestos Disease Awareness Organization (ADAO), leaders in the campaign for a global asbestos ban and justice for asbestos victims. These awards were presented by Laurie Kazan-Allen, the IBAS Coordinator, and Linda Reinstein, Executive Director of the ADAO. During the award ceremony, Mrs. Reinstein told the 300 attendees that when her husband Alan was diagnosed with mesothelioma, the first thing they did was to search the IMIG website looking for medical experts; the help and support of IMIG members during Alan's illness was of inestimable importance to the family and, although sadly Alan lost his fight for life, the hope that one day a cure may be found for this deadly disease motivates her to continue ADAO's fight.
The winners of the 2008 IBAS and ADAO Young Investigators awards, selected by the IMIG Scientific Board and worth €2000 (approximately $2500) each, were announced on September 27 at the closing session of the conference. The 2008 IBAS and ADAO award recipients were:
• Dr. Jenette Creaney from the National Centre for Asbestos-related Disease Research, University of Western Australia for her abstract: The use of mesothelin for monitoring patients with mesothelioma
• Dr. Yasumitsu Nishimura from the Department of Hygiene, Kawasaki Medical School, Okayama, Japan for his abstract: Impairment in cytotoxicity and expression of NK-cell activating receptors on human NK cells caused by exposure to asbestos fibers.
Subscribe to:
Posts (Atom)